HTA Assessment in Germany, Spain, the UK and the EU
This conference provides thorough insights into the national procedures in Germany, Spain, the UK and Ireland.
-
This conference provides thorough insights into the national procedures in Germany, Spain, the UK and Ireland.52.5321298 13.344344
| Wann |
28.09.2017 um 09:00 bis 29.09.2017 um 17:00 |
|---|---|
| Veranstaltungsort | Berlin, Mercure Hotel MOA Berlin |
| Stadt | Berlin |
| Kontaktname | Dr. Henriette Wolf-Klein |
| Kontakttelefon | +49 6221 500-680 |
| Zielgruppe |
This conference addresses the needs of employees in the pharmaceutical industry responsible for market access activities in the various national European markets. Those involved in value-assessment preparation and pricing activities will benefit particularly from this conference. |
| Termin übernehmen |
vCal
iCal
|
HTA/value assessment is an essential tool in many national European healthcare systems.
This conference provides thorough insights into the national procedures in Germany, Spain, the UK and Ireland. It also provides a sound update on European harmonisation efforts in terms of harmonised early advice or joint HTAs.
Early access availability, pricing and pricing strategies will round off the conference, enabling you to optimise your market access strategy for the various European markets.
This conference provides thorough insights into the national procedures in Germany, Spain, the UK and Ireland. It also provides a sound update on European harmonisation efforts in terms of harmonised early advice or joint HTAs.
Early access availability, pricing and pricing strategies will round off the conference, enabling you to optimise your market access strategy for the various European markets.
Themen der Veranstaltung:
- Evidence generation - Harmonised early advice in Europe? Jointly produced European HTAs?
- Real-World Evidence and authorities' acceptance
- Medicines evaluation in Germany, Spain, the UK and Ireland
- Early access possibilities in Europe
- From HTA to pricing
- Real-World Evidence and authorities' acceptance
- Medicines evaluation in Germany, Spain, the UK and Ireland
- Early access possibilities in Europe
- From HTA to pricing
Weitere Informationen über diesen Termin…
FORUM Institut für Management GmbH
Programm
1709232.pdf
—
PDF document,
353 kB (362,222 bytes)
